摘要
基于国内外临床研究报告以及本研究参与人员临床实践经验,通过文献分析、专家函询及专家研讨对神经节苷脂-2(GD2)抗体达妥昔单抗β治疗神经母细胞瘤的相关内容进行深入研究,最终形成包括准备以及要求、药品配制、药品输注、输注期间护理以及不良反应观察与护理等内容的GD2抗体达妥昔单抗β治疗神经母细胞瘤护理专家共识。
Based on clinical research reports in China and abroad,as well as clinical practice experience of the participants in this study,relevant content on ganglioside‐2(GD2)antibody dinutuximab beta for neuroblastoma care was thoroughly investigated through literature analysis,expert inquiries,and expert discussions.The final expert consensus on the use of GD2 antibody dinutuximab beta for neuroblastoma care was formed,which included preparation and requirements,drug configuration,drug infusion,care during infusion,and observation and care of adverse reactions.
作者
王春立
武莹
何梦雪
苏玲
张洪燕
郭欣
程方方
李丹
孙丹
王翠
WANG Chunli;WU Ying;HE Mengxue;SU Ling;ZHANG Hongyan;GUO Xin;CHENG Fangfang;LI Dan;SUN Dan;WANG Cui(Beijing Children′s Hospital,Capital Medical University/National Center for Children′s Health,Beijing 100045 China)
出处
《护理研究》
北大核心
2024年第6期941-947,共7页
Chinese Nursing Research
基金
中华护理学会护理专项项目,编号:ZHKY202202。
